Neuro Phage Pharmaceuticals Cambridge, MA - 02142

Neuro Phage Pharmaceuticals is categorized under Neurologists in Cambridge, MA and active since 2011.

Neuro Phage Pharmaceuticals was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 4242101 by the NAICS.

If you are seeking more information, feel free to contact Jonathan Solomon, Chief Executive Officer at the company’s headquarters by writing to 222 3rd St, Cambridge, Massachusetts MA 02142 or by phoning (617) 714-5468. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Neuro Phage Pharmaceuticals
Contact Person: Jonathan Solomon, Chief Executive Officer
Address: 222 3rd St, Cambridge, Massachusetts 02142
Phone Number: (617) 714-5468
Website Address: neurophage.com
Annual Revenue (USD): Unknown
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Neurologists
SIC Code: 8011
NAICS Code: 4242101
Share This Business:

Neuro Phage Pharmaceuticals was started in 2011 to provide professional Neurologists under the SIC code 8011 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Jonathan Solomon, Chief Executive Officer for inquiries that concern Neuro Phage Pharmaceuticals by calling the company number (617) 714-5468, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Neuro Phage Pharmaceuticals can be found at the coordinates 42.36748,-71.08123 as well as the street address 222 3rd St in Cambridge, Massachusetts 02142.

For its online presence, you may visit Neuro Phage Pharmaceuticals’s website at neurophage.com and engage with its social media outlets through on Twitter and on Facebook.